UK Athletics Ltd pleaded guilty to corporate manslaughter. Keith Davies, 79, then head of sport for the 2017 World Paralympic Athletics Championships, admitted a health and safety charge. Judge Richard Marks KC will sentence UK Athletics and Mr Davies, of Leytonstone, east London, over two days at the Old Bailey from Monday. Corporate manslaughter carries a fine between £180,000 and £20 million, according to guidelines.

BBC Verify has used satellite imagery from other international providers combined with older images from Planet to track the damage caused by Iranian attacks. The facilities are in Saudi Arabia, the United Arab Emirates (UAE), Qatar, Kuwait, Iraq, Jordan, Bahrain and Oman. The actual figure could be higher, with some analysts placing the number of bases hit as high as 28.

One person said that the village “hasn’t got the facilities for a town”

Locals have shared mixed views on several proposed developments in a Cambridgeshire village, with one person saying they “would move” if new houses were built near their home. Separate developers have proposals for up to 470 homes across four parcels of land around the village.

This includes planning applications for up to 75 new homes on land off Back Road in Linton, up to 100 new homes on land south of Horseheath Road, and up to 230 homes on land north of Cambridge Road, alongside a new site for a doctors’ surgery and open space if approved.

Gladman Developments has also proposed up to 65 new homes on land off of Balsham Road although a planning application has not yet been submitted. Horseheath Road is just over 10 minutes away from Balsham Road on foot, while Balsham Road and Back Road are just a two-minute drive away from each another.

The applications have faced some backlash from neighbours living close to the proposed sites. CambridgeshireLive went to Linton to speak with some locals about their thoughts on these potential developments.

Janice Mallows, who has lived in the village for more than 50 years, said: “I don’t like the idea. It is not that they are building houses, it is the effect it would have on the health centre, the dentist, and schools. Unless they build some other things, I think it will be too much.”

She added: “I honestly don’t know why they’ve chosen here but I know it is a very unpopular choice. You have to think, most houses will probably be two cars.”

Janice said that she understands that “houses have to be built somewhere” but feels as though it would reduce the countryside and make the village “too big”.

Hillary Green said that “some development is no doubt necessary because housing is needed” but believes that “big developments are never a great idea”. She feels as though Linton was “always a big village” so “it hasn’t got the facilities for a town”.

The local added: “It could have an impact. The sewage systems are always challenged as well as the local schools. I think there are children who can’t find a place in the local school.”

Hilary believes that the local pharmacy in Linton is “wonderful and necessary”, but it is also “challenged” like many other village pharmacies.

Karen Johnson, 60, who has lived in Linton for more than 20 years, said the village “is not as nice as it used to be”. She said the “whole area is going to be very different in a few years” if the proposals are approved.

She added it would feel like a town and stated that she would move if the proposals at land off Balsham Road near her home proceeded. She added: “We’re very lucky because we look out over a field and it won’t be the same.”

Naomi said that new developments would “absolutely” impact the village. She said: “They’d have to expand some certain things for it to accommodate the new houses. It is possible but they just need to make sure there is enough for the amount of people they are bringing in.”

She said that “people need housing” and there is a “demand for it” and if they “can provide another store, and open other things, it could then make it a bigger village”.

Julie Manning, 43, has run The Dog and Duck pub for 13 years. She said that the “biggest concern for the village is all the new houses”.

“People are getting a bit worried about how many more are being put in place and how many more are being approved”, she said.

Julie added: “It is a worry for the village. The pressure on the doctors’ surgery, the dentist, people are really struggling to get one so it’s hard to see how it is going to work. It is out of our hands I suppose.”

Laurel Thomas (Charlotte Bellamy) could really do with something – or someone – to put a smile on her face after the year she’s had in Emmerdale.

Life has been less than blissful for the café worker in recent times. From a miserable marriage and contentious divorce from Jai Sharma (Chris Bisson), to shacking up with human trafficker Ray Walters (Joe Absolom), capped off with violent son Arthur (Alfie Clarke) abusing her.

What she could do with is a good dose of Netflix and chill.

There was a bit of light relief amongst it all when she had a little dalliance with vicar Charles (Kevin Mathurin) but it wasn’t an ideal match, being one of her besties’ ex and it all fizzled out like damp firework. That said, it won’t be the only time she shares a man with Manpreet (Rebecca Sarker).

*Ross Barton enters the chat *

It’s a small village, it’s hard not to have crossover.

Ross is mostly led by what’s in his pants. He recently tried to get it back on with Manpreet, who told him in no uncertain terms that he was punching. But when did that ever stop him – he simply turns his attention to someone else.

Not Gabby, definitely not Gabby.

As the dancing gets underway, Ross starts to have flirty thoughts towards Laurel.

‘Unbeknown to anyone, [Ross] is a really good dancer and so that’s how I get in with him,’ Charlotte reveals. ‘We sort of Salsa and it all gets a bit steamy, but it’s all really lighthearted and fun, which we need.’

Good old snake hips does it every time.

It’s quite the controversial storyline, because Ross and Laurel is a pairing no one imagined, but also Laurel is sleeping with the guy her step-daughter wants to bed.

Don’t miss a Soaps scoop! Add us as a Preferred Source

As a loyal Metro Soaps reader, we want to make sure you never miss our articles when searching for stories. We have all the latest soaps news, spoilers, videos, and interviews, with a vibrant community of highly engaged readers.

Click the button below and tick Metro.co.uk to ensure you see stories from us first in Google Search.

Advertisement

Add us as a Preferred Source

But this is a big deal for Laurel.

‘Sexual liberation!’ actress Charlotte Bellamy labels Laurel’s next few moves. But she has one big concern for Laurel, after making her way through so many men. ‘I don’t want her to become the local bike!’.

So the fear is that Laurel takes it too far in the name of letting go, but as she confesses herself, with it being such a small area, there’s not much other option if a gal just wants to have fun.

‘It’s a small village. We have to go through everybody really. Well, I have anyway,’ Charlotte told Metro. And why not? Some good looking fellas in that place.

Could Laurel now be awakened to her own desire and go on the prowl around the village? Spoiler alert – she and Ross don’t make it long term because she decides when she’s had enough.

Perhaps the Ray situation had an effect on Laurel. Though Ray was a terrible man, their short-lived romance was fiery and passionate, leaving a lasting impression on Laurel. When asked if Ray awoke something in her, Charlotte said: ‘Totally. That was genuine. But she’s been stung, hasn’t she? So maybe just some frivolous affairs will see her through. But I’m sure it won’t carry on like that.’

Ok so that confirms it – there’s more to come from Laurel’s sexual liberation, if you pardon the expression.

‘He’s her kind of therapy,’ Charlotte shared about Laurel and Ross. ‘Just to have a really surface-level relationship after falling for Ray, and getting burnt.’

But when she’s had her fill, she dumps Ross.

‘That’s why she actually rejects Ross. You’d think it might be the other way around, but of course, she has all the power. We’re going to like that. We should get a good reaction, hopefully.’ Never have we been more proud of Laurel in her whole 24 years in town. Love this for her.

MORE: All new Emmerdale spoiler videos show Laurel taking pleasure in Gabby’s agony

MORE: Lydia has had enough of Sam in all new Emmerdale spoiler video

MORE: All Emmerdale spoilers for next week as a dangerous alliance is formed

WASHINGTON (AP) — A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer.

“While not curing the cancer, it is a very large step forward,” said Dr. Zev Wainberg, of the University of California, Los Angeles, who helped lead the study.

The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.

The daily pills nearly doubled survival time, with fewer severe side effects, in a study that randomly assigned the experimental drug or more chemotherapy to 500 patients whose metastatic, or spreading, cancer had quit responding to prior treatment. The findings were published in the New England Journal of Medicine and presented Sunday at the American Society for Clinical Oncology meeting in Chicago.

Those taking daraxonrasib lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients. While that may seem like a small improvement, Wainberg said it marked the first drug to show a substantial advantage over chemotherapy.

“Having treated pancreatic cancer for 16 years, I actually started crying” when first seeing the study results, Dr. Rachna Shroff of the University of Arizona Cancer Center, who wasn’t involved with the research, said from the ASCO meeting. She was struck by how “patients stayed on this treatment because it was providing durable and meaningful benefit to them.”

The pills’ effects eventually wane but recipients used them for significantly longer than the comparison group stayed on chemotherapy, reporting less pain and a better quality of life as their tumors shrank. Many still were using the drug after the data was analyzed, which Wainberg said means the survival gap may widen as researchers continue tracking them.

Dr. Brian Wolpin, of the Dana-Farber Cancer Institute, presented the findings Sunday. He said the drug should become “a new standard of care” for previously treated metastatic pancreatic cancer, adding that researchers also will explore its use earlier in the disease, including to see if tumor shrinkage might let more patients qualify for surgery.

Side effects most likely to affect pill usage were a rash that can be severe and mouth sores, he said.

Maker Revolution Medicines funded the study and the Food and Drug Administration plans to expedite review of the drug. Meanwhile, the agency is allowing what’s called “expanded access” to the experimental drug for patients who meet certain criteria. The drug garnered public attention when former U.S. Sen. Ben Sasse described on “60 Minutes” how he’s had less pain while taking it. Oncologists are being flooded with requests as the special access program gets started.

Pancreatic cancer is among the most deadly forms in large part because it’s hard to detect before it starts spreading to other organs. The American Cancer Society estimates about 67,000 new cases will be diagnosed in the U.S. this year and more than 52,000 people will die from the disease. The five-year overall survival rate is 13%.

Unlike with other cancers that have benefitted from a variety of chemotherapy alternatives, pancreatic cancer has been harder to tackle.

Cancer specialists not involved in the new research expressed optimism that this may be a turning point in the quest for new options, with dozens of experimental drugs in development.

The new drug targets mutations in the RAS gene family that normally regulates cell growth. So-called KRAS mutations are especially critical in fueling pancreatic cancer. But a structure that made it hard for drugs to stick to the mutated proteins meant this cancer driver was long considered “undruggable.”

Revolution Medicines’ drug uses what’s essentially a molecular glue to bind with multiple KRAS subtypes. Wainberg said researchers next will probe whether the drug worked better in certain of those subtypes.

The drug will change pancreatic cancer treatment, said Dr. Andrew Coveler of the Fred Hutchinson Cancer Center, who wasn’t involved in the research.

“This thing works drastically differently,” he said.

Wainberg said other drugs in development target specific KRAS subtypes. Other approaches in earlier stages of testing include vaccines designed to prevent recurrence after pancreatic cancer surgery by teaching the immune system to recognize the mutated protein.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

“What started as a passion project for Belfast’s whiskey community has grown into something far bigger than we ever imagined”

Belfast will be getting in the ‘spirit’ as Whiskey Week returns with three mini festivals within the one event. Back for its eighth and most ambitious year yet, the event transforms the city into a nine-day celebration of whiskey, food, cocktails and culture.

Running from Friday July 24 to Saturday August 1, 2026, the festival has evolved from a grassroots whiskey gathering into one of the island’s “leading drinks and cultural events”, attracting visitors, distilleries and hospitality partners from across the UK, Ireland and beyond.

This year’s edition promises to be the biggest to date, with organisers unveiling an expanded city-wide programme designed to showcase not only Belfast’s rich whiskey heritage, but also its thriving nightlife, hospitality and creative scene.

Alongside its acclaimed tastings, masterclasses, distillery showcases, whiskey walks and the flagship Whiskey Expo, Belfast Whiskey Week will introduce three new festival strands:

• Belfast Fringe Fest: A new city-wide fringe programme bringing unexpected whiskey experiences, live entertainment, collaborations and pop-up events to venues across Belfast.
• Belfast Cocktail City: A celebration of Belfast’s booming cocktail culture, featuring innovative serves, guest bartenders and whiskey-led cocktail experiences from some of the city’s top bars and hospitality talent.
• Belfast Food Fest: A curated programme pairing world-class whiskey with Belfast’s celebrated food scene, highlighting local chefs, restaurants, producers and immersive dining experiences.

Since launching in 2019, Belfast Whiskey Week has welcomed thousands of visitors through its programme of tastings, tours, talks and immersive events, while helping position Belfast as a major destination on the international whiskey map.

Festival Director Paul Kane said: “What started as a passion project for Belfast’s whiskey community has grown into something far bigger than we ever imagined.

“For our eighth year, we wanted to create a festival that truly celebrates the entire city – its people, its venues, its creativity and its incredible hospitality.

“The introduction of Fringe Fest, Cocktail City and Food Fest allows us to shine a spotlight on every corner of Belfast’s drinks and cultural scene. Belfast Whiskey Week is no longer just a whiskey festival – it’s a celebration of Belfast.”

Michael Stewart, Belfast’s Night Czar added: “Belfast Whiskey Week has become one of the defining events in the city’s cultural and hospitality calendar.

“Its continued growth demonstrates the confidence, creativity and energy that exists within Belfast’s night-time economy. The addition of food, cocktail and fringe programming creates an even broader platform for local businesses, artists and venues to collaborate and showcase what Belfast does best.”

For further details, visit www.belfastwhiskeyweek.com

For all the latest news, visit the Belfast Live homepage here and sign up to our What’s On newsletter here

Strikes hit the bottom line across a wide range of industries, and it is these ripple effects that make industrial action by the RMT such an effective bargaining tool in securing conditions for its members.

The Centre for Economics and Business Research (CEBR) estimated in April that two 24-hour strikes that month cost the economy directly between £130m and £250m in lost working days – both from RMT members themselves and commuters unable to get to work across the city.

However, it said that due to the increased popularity of cycling schemes and remote working, the direct cost of lost work days is higher than it would have been a few years ago.

But the cost is not limited to working days. Sectors such as hospitality and retail take a major hit when there is a Tube strike, particularly businesses in central London, which see a sharp drop in footfall and “less consumer spending”, the CEBR says.

Ahead of the April strike days, pubs and restaurants were braced for nearly a 40 per cent drop in sales, while cafés and coffee shops were expected to lose 34 per cent, according to trade body UKHospitality, which put the overall figure at around £600 million.

TAMPA, Fla. (AP) — The Trump administration is pushing to unleash the power of artificial intelligence for the U.S. military while facing calls to put up guardrails around the rapidly developing technology from some companies — and even notes of caution from top leaders in uniform.

Adm. Frank Bradley, head of U.S. Special Operations Command, told attendees of a recent annual special forces conference in Tampa, Florida, that troops “have to be very careful about how we come to (AI’s) employment and its inspiration into the delivery of lethality.”

Bradley said he can see a future where AI determines what targets to hit but that “we, as humans, have to have the confidence that … it’s going to deliver violence only where we intend it to be delivered.”

The remarks from Bradley, who oversees the units that handle the military’s most difficult and dangerous operations, about the need to ensure safeguards come as his boss, Defense Secretary Pete Hegseth, is pushing to rapidly evolve the military through AI. It is a push that has led to clashes with some tech companies worried about safety measures.

Hegseth has insisted that the Pentagon be allowed to use the technology any legal way it sees fit. He told an audience of SpaceX employees in January he would reject any AI models “that won’t allow you to fight wars” and that his vision for the technology was systems that operate “without ideological constraints that limit lawful military applications.”

AI’s use in the military is part of the Republican administration’s larger push to grow the capability it sees as a unique American advantage even as it faces pressure to ensure responsible safeguards.

President Donald Trump abruptly called off plans to sign a new AI executive order hours before an expected White House ceremony over concerns the measure could dull America’s edge on AI technology.

“We’re leading China, we’re leading everybody, and I don’t want to do anything that’s going to get in the way of that lead,” Trump told reporters.

Two differing AI worlds within the military

When asked about Bradley’s remarks, a Pentagon official said efforts are focused on using AI to create “functional battlefield tools” that can help troops come up with and identify targets more quickly and, as a result, speed up strikes on those targets. The official spoke on condition of anonymity to offer more candid remarks.

Officials at U.S. Special Operations Command talked about AI not as something that will help eliminate targets but rather as a tool that can offer troops more time to focus on their mission.

Sgt. Maj. Andrew Krogman, the top enlisted official for U.S. Special Operations Command, said at the conference that he sees AI handling administrative tasks to free up operators or helping modernize how the command does business.

Melissa Johnson, the top acquisition official for the command, said AI should be “reducing the cognitive workload on mundane tasks.”

“We’re leveraging AI more and more, but it’s not to replace operator judgment, it’s to enhance it,” she added.

Helen Toner, interim executive director at Georgetown University’s Center for Security and Emerging Technology, said those differing descriptions about AI in the military are both true.

“There are a huge number of potential uses for AI in these kinds of bureaucratic settings, which the U.S. military is actively exploring,” Toner said.

Lt. Gen. Michael Conley, head of Air Force Special Operations Command, told a congressional committee in May that his troops used AI “bots” to convert top secret intelligence down to a secret classification within seconds to make it easier to share with drone operators on the ground during the Iran war.

However, there is no doubt that AI also is helping the military find and strike targets.

The center that Toner oversees published a case study two years ago on how the Army’s 18th Airborne Corps used AI to target artillery strikes “just as efficiently as the best unit in recent American history” and with 2,000 fewer service members.

“Human operators are still the ones making crucial decisions, but AI … is making it possible to operate with a new level of speed and scale,” she said.

AI safety has created a public dispute between the Pentagon and Anthropic

The clash over the integration of AI into the military, who ultimately controls the technology and the ethics behind its use has played out in unusually public fashion during the Trump administration.

Hegseth and Anthropic are embroiled in a bitter contract dispute over the company’s concerns about unchecked government use of its technology, including the dangers of fully autonomous armed drones and of AI-assisted mass surveillance that could track dissent.

After CEO Dario Amodei refused to back down over concerns about how the chatbot Claude is used in classified Pentagon networks, both Trump and Hegseth accused Anthropic of endangering national security.

The Pentagon formally labeled the San Francisco-based company a supply chain risk — ending its $200 million defense contract and prohibited other government contractors from working with the company.

Anthropic sued, claiming the Pentagon is illegally retaliating by stigmatizing the company with a designation meant to protect against sabotage of national security systems by foreign adversaries. The Pentagon has since emphasized its turn to Anthropic rivals — including Google, OpenAI and SpaceX — to secure AI technology that can “augment warfighter decision-making in complex operational environments.”

Toner, a former OpenAI board member ousted after a clash with CEO Sam Altman, said “the general public often seems to underestimate the caution with which the U.S. military approaches new technologies.”

“Commanders want their missions to succeed, which means both being able to create lethal effects at scale, and avoiding unintended effects like friendly fire, civilian casualties, or simply identifying targets incorrectly,” she said.